Loading...
Loading...
Among the 3 tracked institutional investors we monitor, NRXP (NRX PHARMACEUTICALS INC) is held with a combined value of $2.37M across 915,821 shares. The largest holder is VANGUARD GROUP INC with a position worth $1.98M. 2 funds increased their holdings.
Total Institutional Value
$2.37M
Total Shares Held
915,821
Institutional Holders
3
Ranked by estimated dollars moved (share change × implied price). 13F data lags up to 45 days.
None this quarter.
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | VANGUARD GROUP INC | $1.98M | 0.00% | +36.4% |
| 2 | BlackRock, Inc. | $210.86K | 0.00% | +19.8% |
| 3 | STATE STREET CORP | $185.28K | 0.00% | - |
As of the latest SEC 13F filings, VANGUARD GROUP INC is the largest institutional holder of NRXP with a position worth $1.98M, representing 0.00% of their portfolio. In total, 3 institutional investors hold NRXP with a combined value of $2.37M.
Institutional investors hold $2.37M worth of NRXP stock across 3 positions. The largest institutional holder is VANGUARD GROUP INC with $1.98M in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For NRXP, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their NRXP positions.
Last Close
$3.75
2026-07-24
YTD
+43.1%
70% of 52-week range